Skip to main content

Advertisement

Table 1 The correlation between clinical characteristics and CDH4 mRNA expression in lung cancer tissue

From: Study on expression of CDH4 in lung cancer

Variable N CDH4 mRNA P
Median (mean, range)
Gender 0.137
 Female 28 0.088(0.190, 0.019–1.367)  
 Male 114 0.075(0.141, 0.012–2.661)  
Age 0.539
 <65 99 0.080(0.167, 0.013–2.661)  
 ≥65 43 0.074(0.115, 0.012–0.517)  
Grade 0.013*
 “High”–“middle” 71 0.068(0.119,0.012-0.932)  
 “Middle-low”–“low” 63 0.108(0.197,0.013-2.661)  
 Censoring 8 0.053(0.071,0.022-0.175)  
Histotype 0.001*
 Squamous 77 0.067(0.116, 0.012–1.367)  
 Adenocarcinoma 58 0.125(0.203, 0.013–2.661)  
 Others 3 0.084(0.096, 0.081–0.125)  
 SCLC 4 0.108(0.106,0.069-0.139)  
Lymph node metastasis 0.733
 0 69 0.092(0.161, 0.012–1.367)  
 1 21 0.067(0.113, 0.013–0.408)  
 2–3 26 0.073(0.187, 0.016–2.661)  
 4–24 24 0.086(0.120, 0.020–0.517)  
 Censoring 2 0.100(0.100, 0.078–0.123)  
Stage 0.580
 I–II 96 0.082(0.172, 0.012–2.661)  
 III–IV 46 0.079(0.106, 0.020–0.517)  
Family history    0.404
 Yes 25 0.070(0.115, 0.012–0.666)  
 No 105 0.083(0.167, 0.013–2.661)  
 Censoring 12 0.070(0.085, 0.040–0.172)  
Smoking state 0.476
 Yes 100 0.083(0.149,0.012-2.661)  
 No 31 0.080(0.180, 0.019–1.367)  
 Censoring 11 0.072(0.088, 0.040–0.172)  
Drinking state    0.216
 Yes 73 0.068(0.164, 0.013–2.661)  
 No 58 0.090(0.146, 0.012–1.367)  
 Censoring 11 0.072(0.088, 0.040–0.172)  
  1. *A p value ≤0.05 was considered statistically significant